[1]
|
Fogelman I,Bessent RG,Cohen HN,et al.Skeletal uptake of diphosphonate method for prediction of post-menopausal osteo-porosis[J].Lancet,1980,2(8196):667-670. |
[2]
|
D'Addabbo A,Rubini G,Mele M,et al.A new method for assessing 99Tcm-MDP bone uptake from a bone scan image:quantitative measurement of radioactivitE in global skeletal regions of interest[J].Nucl Med Commun,1992,13(1):55-60. |
[3]
|
Brenner W,Bohuslavizki KH,Sieweke N,et al.Quantification of diphosphonate uptake based on conventional bone scanning[J].Eur J Nucl Med,1997,24(10):1284-1290. |
[4]
|
Brenner W,Sieweke N,Bohuslavizki KH,et al.Age-and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning[J].Nuklearmedizin,2000,39(5):127-132. |
[5]
|
Thomsen K,Nilas L,Mogensen T,et al.Determination of bone turnover by urinary excretion of 99mTc-MDP[J].Eur J Nucl Med,1986,12(7):342-345. |
[6]
|
Blake GM,Moore AE,Park-Holohan SJ,et al.A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding[J].Nucl Med Commun,2003,24(7):829-835. |
[7]
|
Li WP,Ma DS,Higginbotham C,et al.Development of an in vitro model for assessing the in vivo stability of lanthanide chelates[J].Nucl Med Biol,2001,28(2):145-154. |
[8]
|
Blake GM,Park-Holohan SJ,Fogelman I,et al.Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate[J].J Nucl Med,2002,43(3):338-345. |
[9]
|
Carnevale V,Dicembrino F,Frusciante V,et al.Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age:relevance to the pathogenesis of bone loss[J].J Nucl Med,2000,41(9):1478-1483. |
[10]
|
Israel O,Gips S,Lubushitzky R,et al.Prediction of bone loss in patients with primary hyperparathyroidism using quantitative bone SPECT[J].J Nucl Med,1998,39(9):1614-1617. |
[11]
|
Schmitz A,Risse JH,Textor J,et al.FDG-PET findings of vertebral compression fractures in osteoporosis:preliminary results[J].Osteo-poro Int,2002,13(9):755-761. |
[12]
|
Sarikaya A,Sen S,Hacimahmutoglu S,et al.99mTc(V)-DMSA scintigraphy in monitoring the response of bone disease to vitamin D3 therapy in renal osteodystrophy[J].Ann Nucl Med,2002,16(1):19-23. |
[13]
|
Rymer J,Robinson J,Fogelman I,et al.Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss[J].Osteoporo Int,2001,12(6):478-483. |